1. 137863-17-3
2. Valsartan Methyl Ester
3. Valsartan Impurity E
4. Valsartan Related Compound E
5. N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-l-valine Methyl Ester
6. Methyl (2s)-3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate
7. 7bzq418z0j
8. Chembl326349
9. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Methyl Ester
10. L-valine, N-(1-oxopentyl)-n-[[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, Methyl Ester
11. Unii-7bzq418z0j
12. Valsartan Impurity E [usp-mc]
13. Schembl2251
14. Schembl21619424
15. Dtxsid50468616
16. Bdbm50282365
17. Zinc27079783
18. Akos015899737
19. Akos037647709
20. As-74538
21. Valsartan Related Compound E [usp-rs]
22. D92869
23. A886382
24. Q27268035
25. Methyl N-pentanoyl-n-{[2'-(1h-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-l-valinate
26. Methyl N-pentanoyl-n-{[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-l-valinate
27. N-valeryl-n-[(2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl]-(l)-valine Methyl Ester
28. (2s)-2-[pentanoyl[[2'-(1h-tetrazole-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutyric Acid Methyl Ester
29. (s)-3-methyl-2-{pentanoyl-[2''-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric Acid Methyl Ester
30. (s)-methyl 2-(n-((2\'-(1h-tetrazol-5-yl)-[1,1\'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
31. (s)-methyl2-(n-((2'-(1h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
32. L-valine,n-(1-oxopentyl)-n-[[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,methylester
33. Methyl (2s)-3-methyl-2-(n-{[2'-(2h-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoate
34. Methyl (2s)-3-methyl-2-[n-({4-[2-(1h-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoate
35. Methyl (2s)-3-methyl-2-[pentanoyl-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate
36. N-[2 Inverted Exclamation Mark -(1h-tetrazol-5-yl)biphenyl-4-yl Methyl]-n-valeryl-(l)-valine Methyl Ester
Molecular Weight | 449.5 g/mol |
---|---|
Molecular Formula | C25H31N5O3 |
XLogP3 | 4.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 11 |
Exact Mass | 449.24268987 g/mol |
Monoisotopic Mass | 449.24268987 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 623 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
CAS Number : 137863-17-3
End Use API :
End Use API : Valsartan
About the Company : Pluvia Consumer Health is a multinational pharmaceutical company with its head office in Turkey/Istanbul & with unique molecules & know-how. Our portfolio contains several specific APIs...
CAS Number : 137863-17-3
End Use API :
End Use API : Valsartan
About the Company : Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise integrating drug research and development, production, and sales. It is located ...
MARKET PLACE
LOOKING FOR A SUPPLIER?